Search

Current filters: HIV drugs, HIV

Dovato (dolutegravir + 3TC) in initial HIV treatment

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Biktarvy begins to get listed on provincial drug formularies

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Dovato approved in Canada for HIV treatment

2019, CATIE
Research summary - Webpage

Update of recommendations on first- and second-line antiretroviral regimens

2019, World Health Organization (WHO)
Guideline or manual - PDF
More info

Truvada vs. Descovy for HIV prevention

From TreatmentUpdate 231
2019, CATIE
Research summary - Webpage

Higher levels of dolutegravir in older people not linked to side effects

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Large French study examines neuropsychiatric side effects with integrase inhibitors

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Can high-dose dolutegravir be a rescue therapy?

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Delstrigo

2019, CATIE
Fact sheet - Webpage

De-simplifying single-tablet regimens for HIV treatment

2019, CATIE
Research summary - Webpage